### Research Roundup: Leveraging AI to Identify Type II Diabetes, Boosting Vaccine Immunity, and Simulating Touch #### Using AI to Detect Subtypes of Type II Diabetes In a groundbreaking study published in *Nature* on December 23, a team of researchers led by Mike Snyder, a former postdoctoral scholar at Stanford Medicine, has developed an AI-driven method to sub-classify Type II diabetes using continuous glucose monitors (CGMs). Type II diabetes, which affects around 13% of the U.S. population, is a complex condition with various underlying causes, including genetics, body weight, and exercise. Traditional diagnostic methods often fail to capture these nuances, leading to a one-size-fits-all approach in treatment. The researchers tested their AI mechanism on a group of 54 participants, including those with prediabetes and those without. The AI analyzed the glucose level patterns, such as peaks and troughs, recorded by the CGMs to identify different subtypes of Type II diabetes. The results were highly accurate, with the AI correctly identifying subtypes in 90% of the cases. This development is crucial because it allows for more personalized and effective treatment. As Tracey McLaughlin, an Endocrinology Professor at Stanford, explained, "Depending on what type you have, some drugs will work better than others." This AI-driven classification could lead to more tailored medical interventions, improving patient outcomes and reducing the trial-and-error process in diabetes management. #### A New Understanding of Vaccine Immunity A recent paper published in *Nature* on January 2, led by Bali Pulendran, a professor of microbiology and immunology at Stanford, offers a novel insight into why some vaccines provide long-lasting immunity while others, like the Influenza vaccine, do not. The study involved participants who received either doses of a bird flu vaccine with an adjuvant, a substance that enhances the immune response, or doses without it. Blood samples were collected periodically and analyzed using machine learning techniques. The researchers hypothesized that megakaryocytes, cells responsible for producing platelets, play a significant role in the immune response to vaccines. To test this hypothesis, they administered the bird flu vaccine to mice along with a drug that increased the number of megakaryocytes in the bloodstream. The results were striking: the mice showed a dramatic increase in the number of antibodies, indicating a stronger immune response. Further research revealed that megakaryocytes produce molecules that help maintain the health of antibody-producing cells. Pulendran is now exploring ways to measure the duration of the antibody response. He suggests developing a simple PCR assay, or "vaccine chip," that can measure gene expression levels in the blood a few days after vaccination. This tool could help predict how long the immunity will last, providing valuable information for vaccine design and public health strategies. #### Simulating Touch Through a New Haptic Device Researchers at Stanford Engineering have made significant strides in the field of haptic technology with the development of a pressure-based haptic sleeve that simulates realistic touch. Unlike previous haptic devices that relied on vibration, this new sleeve aims to provide a more accurate and comfortable tactile experience. The initial design of the haptic sleeve involved a battery-powered system with inflatable pouches. However, the researchers encountered a challenge: the pouches would press against the skin with excessive force, making the device uncomfortable and reducing its effectiveness. Cosima du Pasquier, the lead author and a postdoc in mechanical engineering at Stanford, noted, "If you put air into a balloon next to your skin but don’t anchor it there, it’s going to expand in all directions. You’re going to waste most of the inflation potential." To address this issue, the team settled on a knitted fabric made from nylon and cotton. The fabric was both sturdy enough to hold the inflatable pouches against the skin and flexible enough to allow for comfortable movement. After knitting the sleeve on a machine, the researchers heated it to stiffen the fibers, enhancing its structural integrity. The potential applications of this haptic sleeve are vast. Allison Okamura, a Stanford mechanical engineering professor, highlighted the need for further research to understand how people interpret and respond to this type of haptic information. This could lead to advancements in virtual reality, prosthetics, and other areas where realistic touch simulation is crucial. The development of this device marks a significant step forward in haptic technology, promising more immersive and realistic tactile experiences. ### Conclusion This week's Research Roundup from Stanford highlights three innovative developments in the fields of diabetes management, vaccine immunity, and haptic technology. The AI-driven classification of Type II diabetes subtypes could revolutionize treatment approaches, making them more personalized and effective. The discovery of megakaryocytes' role in enhancing vaccine immunity offers new insights into vaccine design and longevity. Lastly, the pressure-based haptic sleeve represents a significant improvement in touch simulation, with potential applications in various technological and medical fields. These advancements underscore the ongoing commitment of Stanford researchers to pushing the boundaries of science and technology for the betterment of human health and experience.